Glaxo unveil 'blockbuster' drugs

Drugs group GlaxoSmithKline today unveiled a range of new drugs to treat heart disease, cancer and breathing disorders that it said could become “blockbusters”.

The company was due to reveal 82 new products, 45 extensions of existing product lines and 20 vaccines at a research and development presentation to investors.